Fri, Aug 1, 2014, 8:42 AM EDT - U.S. Markets open in 48 mins.


% | $
Click the to save as a favorite.

Isis Pharmaceuticals, Inc. Message Board

  • dinepat203 dinepat203 Dec 17, 2012 9:56 AM Flag

    ISIS had 2 approvals by FDA in past but both failed in Market.

    Isis has several drugs in clinical development. However, only two have reached the market. One is Vitravene, for an AIDS-related viral eye infection, approved for sale in 1997. Vitravene is no longer sold, because new HIV drugs have reached the market. Another Isis drug, alicaforsen, was licensed to Atlantic Pharmaceuticals in 2007. Atlantic sells the drug for inflamatory bowel disease and related conditions.

    Isis developed Kynamro and then licensed the potential treatment to Genzyme, which will market the drug if it is approved.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
30.99-0.77(-2.42%)Jul 31 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.